UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

Nature immunology, 2022-02, Vol.23 (2), p.210-216

2022

Volltextzugriff (PDF)

National trends in retreatment of HCV due to reinfection or treatment failure in Australia

Journal of hepatology, 2023-02, Vol.78 (2), p.260-270

2023

Volltextzugriff (PDF)

Management of acute HCV infection in the era of direct-acting antiviral therapy

Nature reviews. Gastroenterology & hepatology, 2018-07, Vol.15 (7), p.412-424

2018

Volltextzugriff (PDF)

Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection

Medical journal of Australia, 2021-04, Vol.214 (6), p.279-280

2021

Volltextzugriff (PDF)

How I manage severe bacterial infections in people who inject drugs

Clinical microbiology and infection, 2024-07, Vol.30 (7), p.877-882

2024

Volltextzugriff (PDF)

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia

PloS one, 2023-11, Vol.18 (11), p.e0289907-e0289907

2023

Volltextzugriff (PDF)

Management of Hepatitis C Virus/HIV Coinfection Among People Who Use Drugs in the Era of Direct-Acting Antiviral—Based Therapy

Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S118-S124

2013

Volltextzugriff (PDF)

One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review

International journal of infectious diseases, 2021-11, Vol.112, p.63-65

2021

Volltextzugriff (PDF)

Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection

Nature communications, 2024-04, Vol.15 (1), p.3315-3315, Article 3315

2024

Volltextzugriff (PDF)

Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs

Infectious disease clinics of North America, 2018-06, Vol.32 (2), p.371-393

2018

Volltextzugriff (PDF)

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

PloS one, 2015-07, Vol.10 (7), p.e0131437-e0131437

2015

Volltextzugriff (PDF)

Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection

Hepatology (Baltimore, Md.), 2010-11, Vol.52 (4), p.1216-1224

2010

Volltextzugriff (PDF)

Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review

Clinical infectious diseases, 2023-08, Vol.77 (Supplement_3), p.S238-S244

2023

Volltextzugriff (PDF)

Plasma interferon‐gamma‐inducible protein‐10 (IP‐10) levels during acute hepatitis C virus infection

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2124-2134

2013

Volltextzugriff (PDF)

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy

EBioMedicine, 2024-04, Vol.102, p.105054-105054, Article 105054

2024

Volltextzugriff (PDF)

Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals

PloS one, 2013-04, Vol.8 (4), p.e61297-e61297

2013

Volltextzugriff (PDF)

The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC

Annals of clinical and translational neurology, 2023-08, Vol.10 (8), p.1338-1352

2023

Volltextzugriff (PDF)

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

Hepatology (Baltimore, Md.), 2008-10, Vol.48 (4), p.1062-1069

2008

Volltextzugriff (PDF)

Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study

Journal of the International AIDS Society, 2023-09, Vol.26 (9), p.e26168-e26168

2023

Volltextzugriff (PDF)

Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study

JHEP reports, 2023-10, Vol.5 (10), p.100867-100867, Article 100867

2023

Volltextzugriff (PDF)

Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort

PloS one, 2016-06, Vol.11 (6), p.e0150655

2016

Volltextzugriff (PDF)

HIV and hepatitis C coinfection

Journal of gastroenterology and hepatology, 2008-07, Vol.23 (7pt1), p.1000-1008

2008

Volltextzugriff (PDF)

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM

Current opinion in infectious diseases, 2019-02, Vol.32 (1), p.31-37

2019

Volltextzugriff (PDF)

Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men

PloS one, 2016-09, Vol.11 (9), p.e0162002-e0162002

2016

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(211)

Publikationsform

Artikel
(242)
Buchkapitel
(3)

Sprache

Englisch
(245)

Erscheinungsjahr

n.n

Thema

Science & Technology
(194)
Life Sciences & Biomedicine
(180)
Humans
(154)
Male
(92)
Infectious Diseases
(86)
Female
(76)
Adult
(70)
Hepatitis C
(66)
Hiv
(64)
Immunology
(54)
Hepatitis C Virus
(53)
Human Immunodeficiency Virus
(53)
Middle Aged
(53)
Antiviral Agents - Therapeutic Use
(52)
Gastroenterology & Hepatology
(52)
Hepatitis C - Drug Therapy
(41)
Hepatitis
(40)
Hiv Infections - Complications
(40)
Infections
(37)
Hepatitis C, Chronic - Drug Therapy
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

National trends in retreatment of HCV due to reinfection or treatment failure in Australia

Management of acute HCV infection in the era of direct-acting antiviral therapy

Persistent symptoms up to four months after community and hospital‐managed SARS‐CoV‐2 infection

How I manage severe bacterial infections in people who inject drugs

Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial

Management of Hepatitis C Virus/HIV Coinfection Among People Who Use Drugs in the Era of Direct-Acting Antiviral—Based Therapy

One-third of people who inject drugs are at risk of incomplete treatment for Staphylococcus aureus bacteraemia: a retrospective medical record review

Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection

Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection

Direct-Acting Antiviral Therapy for Treatment of Acute and Recent Hepatitis C Virus Infection: A Narrative Review

Plasma interferon‐gamma‐inducible protein‐10 (IP‐10) levels during acute hepatitis C virus infection

Predictors of liver disease progression in people living with HIV-HBV co-infection on antiretroviral therapy

Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals

The kynurenine pathway relates to post‐acute COVID‐19 objective cognitive impairment and PASC

A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand

Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study

Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study

Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort

HIV and hepatitis C coinfection

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM

Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men

Suchergebnisse filtern